Astria Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Astria Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2014 to Q3 2024.
  • Astria Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 56.4M shares, a 101% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 56.4M +28.4M +101% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 54.9M +26.9M +96% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 54.9M +26.9M +96.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 41M +13.5M +49.2% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 28M +12.3M +78.1% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 28M +15M +115% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 28M +15M +115% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 27.5M +14.5M +111% Dec 31, 2022 10-K 2024-03-04
Q3 2022 15.7M +2.74M +21.1% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 13M -63.9M -83.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 13M -10.4M -44.4% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 13M +9.67M +289% Dec 31, 2021 10-K 2023-03-22
Q3 2021 13M -7.07M -35.2% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 76.9M +58.1M +309% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 23.4M +5.52M +30.8% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 3.35M -9.09M -73.1% Dec 31, 2020 10-K 2022-03-10
Q3 2020 20.1M +8.36M +71.4% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 18.8M +7.27M +62.9% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 17.9M +6.4M +55.7% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 12.4M +5.29M +74.1% Dec 31, 2019 10-K/A 2021-04-19
Q3 2019 11.7M -59.3M -83.5% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 11.6M -59.5M -83.7% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 11.5M -17.5M -60.4% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 7.14M +4.78M +202% Dec 31, 2018 10-K 2020-03-10
Q3 2018 71M +48.1M +210% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 71M +48.6M +216% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 29M +9.04M +45.2% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 2.36M -16.5M -87.4% Dec 31, 2017 10-K 2019-03-14
Q3 2017 22.9M +4.26M +22.8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 22.5M +7.1M +46.2% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 20M +4.64M +30.2% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 18.8M +3.5M +22.9% Dec 31, 2016 10-K 2018-03-15
Q3 2016 18.6M +3.34M +21.8% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 15.4M +83.6K +0.55% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 15.4M Mar 31, 2016 10-Q 2016-05-12
Q4 2015 15.3M +14.8M +3005% Dec 31, 2015 10-K 2017-03-16
Q3 2015 15.3M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 15.3M Jun 30, 2015 10-Q 2015-08-13
Q4 2014 493K Dec 31, 2014 10-K 2016-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.